Cargando…
Neonatal Screening for Congenital Adrenal Hyperplasia in Indian Newborns with Reflex Genetic Analysis of 21-Hydroxylase Deficiency
Congenital adrenal hyperplasia (CAH), screened for in neonates, is the second most common endocrinopathy after congenital hypothyroidism.Newborn screening for CAH due to CYP21A2 deficiency is performed by immunologic assay for 17-hydroxyprogesterone (17-OHP). The second-tier test for confirmation of...
Autores principales: | Tippabathani, Jayakrishna, Seenappa, Venu, Murugan, Alagupandian, Phani, Nagaraja Mahishi, Hampe, Mahesh H., Appaswamy, Giridharan, Sadashiv Gambhir, Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053538/ https://www.ncbi.nlm.nih.gov/pubmed/36975848 http://dx.doi.org/10.3390/ijns9010009 |
Ejemplares similares
-
Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020) -
Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Lee, Peter A., et al.
Publicado: (2010) -
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2019) -
Height augmentation in 11β-hydroxylase deficiency congenital adrenal hyperplasia
por: Nour, Munier A, et al.
Publicado: (2015) -
Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia
por: Kolahdouz, Mahsa, et al.
Publicado: (2015)